David Rolfe Wedgewood Partners
David Rolfe is the chief investment officer of Wedgewood Partners, known for a concentrated growth portfolio of large-capitalization companies. The firm emphasizes quality franchises, high returns on capital, and limited diversification across only a few dozen names at most. Rolfe’s commentaries are followed by investors who prefer focused growth ownership over broad index replication.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$107M |
| 2 |
Qualcomm
QCOM
|
+$67.4M |
| 3 |
PayPal
PYPL
|
+$53.7M |
| 4 |
TJX Companies
TJX
|
+$49.1M |
| 5 |
Tractor Supply
TSCO
|
+$46.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
LKQ Corp
LKQ
|
+$117M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$113M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$103M |
| 5 |
Booking.com
BKNG
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.34% |
| 2 | Technology | 17.82% |
| 3 | Consumer Discretionary | 17.26% |
| 4 | Consumer Staples | 11% |
| 5 | Energy | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Consolidated Edison
ED
$39.3B
| $1M | 0.03% |
12,900
| – | – |
|
27
Verizon
VZ
$205B
| $973K | 0.03% |
19,975
+110
| +0.6% | +$5.52K |
|
28
Paychex
PAYX
$44.3B
| $914K | 0.02% |
15,525
-1,175
| -7% | -$71.4K |
|
29
Annaly Capital Management
NLY
$17.5B
| $731K | 0.02% |
16,469
-3,125
| -16% | -$133K |
|
30
Ecolab
ECL
$78.9B
| $717K | 0.02% |
5,722
| – | – |
|
31
Johnson & Johnson
JNJ
$651B
| $653K | 0.02% |
5,250
| – | – |
|
32
Tapestry
TPR
$26B
| $506K | 0.01% |
12,250
-9,875
| -45% | -$372K |
|
33
NOV
NOV
$7.28B
| $423K | 0.01% |
10,575
-3,250
| -24% | -$127K |
|
34
AT&T
T
$173B
| $397K | 0.01% |
12,677
| – | – |
|
35
PepsiCo
PEP
$196B
| $359K | 0.01% |
3,215
| – | – |
|
|
MN
36
DELISTED
MANNING & NAPIER, INC.
MN
| $319K | 0.01% |
56,000
+10,000
| +22% | +$65.8K |
|
37
Boeing
BA
$169B
| $221K | 0.01% |
+1,250
| New | +$213K |
|
|
38
LKQ Corp
LKQ
$6.52B
| – | – |
-3,830,200
| Closed | -$117M |
|
|
MJN
39
DELISTED
Mead Johnson Nutrition Company
MJN
| – | – |
-1,451,913
| Closed | -$103M |
|
Similar funds
David Rolfe's Q1 2017 Portfolio in Review
As of Q1 2017, David Rolfe held 39 positions worth $3.88B, down 5.2% from $4.1B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
David Rolfe withdrew a net $429M in Q1 2017, closing 2 positions and reducing 21 holdings. Its most notable exit was LKQ Corp, an estimated $117M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Rolfe opened a new position in Edwards Lifesciences worth $107M.
- David Rolfe's largest Q1 2017 buy was Edwards Lifesciences: 3,411,216 shares worth $107M.
- David Rolfe added most to Qualcomm in Q1 2017, an estimated $67.4M increase.
- David Rolfe's biggest Q1 2017 reduction was Apple, cutting an estimated $172M.
- David Rolfe fully exited LKQ Corp in Q1 2017, selling an estimated $117M.
- David Rolfe's ten largest holdings make up 67% of its $3.88B portfolio in Q1 2017.
- David Rolfe opened 3 new positions and closed 2 in Q1 2017.
- David Rolfe's portfolio value fell 5.2% quarter-over-quarter to $3.88B.
Based on Wedgewood Partners's 13F filing for Q1 2017, filed 15 May 2017.